NEW YORK (GenomeWeb) – Natera reported after the close of the market on Tuesday that its second quarter 2017 revenues were up 3 percent.

The San Carlos, California-based molecular diagnostics company reported total Q2 2017 revenues of $53.6 million compared to $52.0 million in Q2 2016, beating analysts' average estimate of $50.6 million. Total revenues included $52.3 million in product revenue and $1.3 million in licensing and other revenue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.

Sponsored by

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.